Abstract
Coronavirus disease 2019 (COVID-19) specifically in diabetic patients has attracted attention worldwide due to the poor prognosis of infection, compromised immunity and delayed response to medicines leading to increased death rate. Several pathophysiological explanations can be linked in support of connection between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) alias COVID-19 and diabetes severity. In patients with diabetes, the innate immune system is compromised and the disease can be triggered by SARS-CoV-2. The exaggerated and inappropriate cytokine response can be evidenced in both diabetic and COVID-19 patients. This is evidenced by the elevated levels of IL-6 in their blood. It has been known that people with diabetes are more prone to having an inflammatory cytokine storm, which can cause acute respiratory distress syndrome (ARDS). Anti-viral drugs and agents can help lower blood sugar levels, but their use should be carefully monitored to see if they can also interact with COVID-19 treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Clinical Biochemistry and Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
